Basics
Description
Infectious agent is an arbovirus, an RNA member of the Flaviviridae family. ‚
Etiology
- Vector-borne virus
- Transmitted by infected mosquitoes in late summer/early fall
- Wild birds are primary reservoir hosts; humans are infected by cross-feeding mosquitoes.
- Introduced to Western Hemisphere in 1999; became more widespread owing to vector of Culex mosquito and is now endemic in North America
- Infection after blood transfusion and solid-organ transplant can occur.
- There are case reports of occupational exposure and infection of lab workers via percutaneous inoculation.
- Following recovery, immunity is considered lifelong. Reoccurrence is rare
- The 2011 outbreak had a mortality rate of 4 " “5%. Cases were reported in 48 states.
Infection via transplacental transmission and breast-feeding has been reported. ‚
Diagnosis
Signs and Symptoms
- Variable severity of illness:
- 80% asymptomatic
- 20% mild symptoms, flu-like illness
- ¢ ˆ ¼1/150 with CNS involvement (encephalitis, meningitis)
- Incubation period is usually 2 " “6 days but can be up to 14 days in average patient and up to 21 days in immunocompromised patient.
- Symptoms have a sudden onset and last <1 wk with mild infection.
- Mortality rate in severe cases is estimated at 7%.
- Severity of illness is related to degree of CNS invasion by virus. Risk is enhanced with increased age and immunosuppression
- Immunocompromised patients have prolonged viremia, delayed development of antibody, and increased likelihood of severe disease.
- Persistent symptoms of fatigue, memory impairment, weakness, and headache have been reported to last for 1 " “2 mo
- Patients >60 yr, if infected, are at higher risk for developing more severe disease and neurologic consequences.
- Advanced age is the most important risk factor for death.
History
- General:
- Fever
- Malaise
- Anorexia
- Headache
- Acute phase resolves within several days but fatigue and weakness may persist for weeks
- Neurologic:
- Altered mental status (change in level of consciousness, confusion, agitation, irritability)
- Severe, diffuse muscle weakness; may be asymmetric and involve the face
- Flaccid paralysis, which may resemble poliomyelitis-like syndrome, associated with anterior horn cell injury. Cranial nerve and bulbar abnormalities have been reported
- May resemble Guillain " “Barre syndrome
- Seizures
- Encephalitis more commonly reported in adults and meningitis in children
- GI:
- Nausea, vomiting, diarrhea, anorexia
- Abdominal pain
- Musculoskeletal:
- Myalgia
- Arthralgia
- Back pain
- Respiratory:
- Ophthalmologic:
Physical Exam
- General:
- Temperature >38 ‚ °C (>100 ‚ °F)
- Transient maculopapular rash
- Rhabdomyolysis
- Neurologic:
- Altered mental status
- Hyporeflexia, areflexia
- Ataxia
- Extrapyramidal signs
- Cranial nerve palsies, paresis
- Myoclonus
- Profound motor weakness
- Flaccid paralysis
- GI:
- Hepatosplenomegaly, hepatitis, pancreatitis
- Musculoskeletal:
- Hematologic:
- Dermatologic:
- Rash (maculopapular or morbilliform on neck, trunk, extremities) usually lasting <1 wk
- Cardiovascular:
- Ophthalmologic:
- Optic neuritis
- Vitritis
- Chorioretinitis
Essential Workup
- Most sensitive screening test is serologic testing of CSF and serum for IgM antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA) and culture.
- Centers for Disease Control and Prevention (970-221-6400)
- Can be detected during 1st 4 days of illness, nearly all tests are positive by day 7 " “8; may remain positive up to 1 yr after infection
- Procedures for submitting samples vary by state.
- Refer to local public health department for guidelines.
Diagnosis Tests & Interpretation
Lab
- CSF:
- Pleocytosis with lymphocyte predominance
- Elevated protein
- Normal glucose
- CBC:
- WBCs may be mildly elevated (50%) or normal.
- Leukopenia may be present (15%).
- Anemia can occur.
- Chemistry:
- Hyponatremia sometimes seen:
- Cause uncertain, possibly syndrome of inappropriate antidiuretic hormone (SIADH) when CNS involvement exists
- Pancreatitis (rare)
- Fulminant hepatitis (rare)
Imaging
- CT head usually normal
- MRI can be useful to identify CNS inflammation:
- 1/3 of patients show abnormality.
- Imaging findings generally nonspecific but may include enhancement of leptomeninges and/or periventricular white matter or can mimic demyelinating process.
Diagnostic Procedures/Surgery
- Lumbar puncture
- MAC-ELISA may be used on serum and CSF samples
Differential Diagnosis
- Other causes of meningitis:
- Bacterial
- Viral
- Tuberculous
- Fungal
- Other causes of viral encephalitis:
- Other arboviruses, especially St. Louis encephalitis virus
- Enterovirus, particularly in patients ≤16 yr of age
- Herpes simplex virus (HSV)
- Cytomegalovirus (CMV)
- Epstein " “Barr virus (EBV)
- Mumps virus
- Varicella zoster virus
- Rabies virus
- Intracranial abscess
- CNS vasculitis
- Nonspecific viral syndrome
- Gastroenteritis
Treatment
Initial Stabilization/Therapy
Ed Treatment/Procedures
- Supportive care
- IV fluids for signs of dehydration
- For signs of meningitis, administer antibiotics pending results of CSF.
- Consider acyclovir if index of suspicion for the only treatable cause of viral encephalitis, HSV, is high.
- Administer antipyretics and pain medications.
- No known effective antiviral therapy or vaccine
- No controlled studies proving effectiveness of interferonα-2b, ribavirin, corticosteroids, anticonvulsants, or osmotic agents
Follow-Up
Disposition
Admission Criteria
- Neurologic symptoms
- Dehydration
- Concerning risk factors (advanced age, immunocompromise)
Discharge Criteria
- No signs of CNS involvement (encephalitis, meningitis)
- Able to tolerate oral solutions
Followup Recommendations
Neurologist to monitor for potential ongoing residual. ‚
Pearls and Pitfalls
Consider HSV in differential, since HSV is treatable. ‚
Additional Reading
- Centers for Disease Control and Prevention (CDC): Interim guidelines for the evaluation of infants born to mothers infected with West Nile Virus during pregnancy. MMWR Morb Mortal Wkly Rep. 2004;53:154 " “157.
- Hayes ‚ EB, O 'Leary ‚ DR. West Nile virus infection: A pediatric perspective. Pediatrics. 2004;113:1375 " “1381.
- Loeb ‚ M, Hanna ‚ S, Nicolle ‚ L, et al. Prognosis after West Nile virus infection. Ann Intern Med. 2008;149:232 " “241.
- Petersen ‚ LR, Marfin ‚ AA, Gubler ‚ DJ. West Nile virus. JAMA. 2003;290:524 " “528.
- Peterson ‚ LR, Hayes ‚ EB: West Nile virus in the Americas. Med Clin North Am. 2008;92:1307 " “1322.
- West Nile Virus: Information and Guidance for Clinicians. Available at http://www.cdc.gov/ncidod/dvbid/westnile/clinicians
- Zak ‚ IT, Altinok ‚ D, Merline ‚ JR, et al. West Nile virus infection. AJR Am J Roentgenol. 2005;184(3):957 " “961.
See Also (Topic, Algorithm, Electronic Media Element)
Meningitis; Encephalitis, HSV ‚
Codes
ICD9
- 066.40 West Nile Fever, unspecified
- 066.41 West Nile Fever with encephalitis
- 066.42 West Nile Fever with other neurologic manifestation
- 066.49 West Nile Fever with other complications
- 066.4 West nile fever
ICD10
- A92.30 West Nile virus infection, unspecified
- A92.31 West Nile virus infection with encephalitis
- A92.32 West Nile virus infection with oth neurologic manifestation
- A92.39 West Nile virus infection with other complications
- A92.3 West Nile virus infection
SNOMED
- 417093003 Disease due to West Nile virus (disorder)
- 392662004 West Nile encephalitis (disorder)
- 430397002 disorder of nervous system due to West Nile virus (disorder)
- 404233006 West Nile meningitis (disorder)
- 397420007 West Nile fever without encephalitis (disorder)